2001
DOI: 10.1067/mjd.2001.113692
|View full text |Cite
|
Sign up to set email alerts
|

Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
94
1
1

Year Published

2004
2004
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 145 publications
(99 citation statements)
references
References 19 publications
3
94
1
1
Order By: Relevance
“…115,134 A recent study showed recurrence rates of 30% after standard excision and 11% after Mohs micrographic surgery. 139 Although SC is thought to be resistant to radiation therapy, some case reports have shown remission with treatment. 140 Exenteration is advocated in situations where the orbit or significant portions of the bulbar conjunctiva are involved.…”
Section: Sebaceous Carcinoma Key Pointsmentioning
confidence: 98%
“…115,134 A recent study showed recurrence rates of 30% after standard excision and 11% after Mohs micrographic surgery. 139 Although SC is thought to be resistant to radiation therapy, some case reports have shown remission with treatment. 140 Exenteration is advocated in situations where the orbit or significant portions of the bulbar conjunctiva are involved.…”
Section: Sebaceous Carcinoma Key Pointsmentioning
confidence: 98%
“…Standard surgical excision of visible tumor with 5 to 6 mm margins is the most commonly used surgical approach for SCs. 41 This recommendation is based on studies with ocular SCs. 42 Local recurrence with standard excision of ocular SCs is reported to occur in 36% of patients within 5 years, and the 5-year mortality rate is reported from 18% to 30%.…”
Section: Surgical Treatmentmentioning
confidence: 99%
“…As sebaceous carcinoma is infiltrative, particularly if ocular in origin, MMS is recommended, but wide excision may be used for extraocular tumours. 58,59 For more advanced orbital lesions, exenteration may be required. Recurrence has been reported to vary from 6% to 56% at 5 years.…”
Section: Sebaceous Carcinomamentioning
confidence: 99%
“…Recurrence has been reported to vary from 6% to 56% at 5 years. 58,59 Appropriate imaging such as MR should be done to detect metastases. Regional lymph node metastases have been reported at 2.4%.…”
Section: Sebaceous Carcinomamentioning
confidence: 99%